MedTrace Logo

Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy

NCT07560735 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-01

No results posted yet for this study

Summary

This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM

Conditions

  • Dry Eye

Interventions

DRUG

Lifitegrast Ophthalmic Solution 5.0% (Xiidra)

30 subjects with DED will receive lifitegrast ophthalmic solution 5.0% (Xiidra)

Sponsors & Collaborators

  • Toyos Clinic

    lead OTHER

Principal Investigators

  • Melissa Toyos, MD · West Tennessee Eyecare dba Toyos Clinic

  • Rolando Toyos, MD · West Tennessee Eyecare dca Toyos Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-09-30
Completion
2027-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07560735 on ClinicalTrials.gov